Abstract
This article attempted to introduce the child psychiatric research and clinical practice reader to the possibilities for addressing drug evaluation questions from an epidemiologic research perspective. Pharmacoepidemiology would extend the current research model by ensuring that knowledge of drug prevalence is routinely made available. In addition, it would develop methods for assessing long-term effectiveness and systematic methods for assessing drug safety. Controversial questions about the role of psychopharmacology in the management of children would be well addressed by the provision of empiric data to advocates who support or challenge these practices.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 77-95 |
| Number of pages | 19 |
| Journal | Child and Adolescent Psychiatric Clinics of North America |
| Volume | 4 |
| Issue number | 1 |
| State | Published - 1995 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Psychiatry and Mental health
Cite this
Psychiatric pharmacoepidemiology for children. / Zito, J. M.; Riddle, Mark A.
In: Child and Adolescent Psychiatric Clinics of North America, Vol. 4, No. 1, 1995, p. 77-95.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Psychiatric pharmacoepidemiology for children
AU - Zito, J. M.
AU - Riddle, Mark A
PY - 1995
Y1 - 1995
N2 - This article attempted to introduce the child psychiatric research and clinical practice reader to the possibilities for addressing drug evaluation questions from an epidemiologic research perspective. Pharmacoepidemiology would extend the current research model by ensuring that knowledge of drug prevalence is routinely made available. In addition, it would develop methods for assessing long-term effectiveness and systematic methods for assessing drug safety. Controversial questions about the role of psychopharmacology in the management of children would be well addressed by the provision of empiric data to advocates who support or challenge these practices.
AB - This article attempted to introduce the child psychiatric research and clinical practice reader to the possibilities for addressing drug evaluation questions from an epidemiologic research perspective. Pharmacoepidemiology would extend the current research model by ensuring that knowledge of drug prevalence is routinely made available. In addition, it would develop methods for assessing long-term effectiveness and systematic methods for assessing drug safety. Controversial questions about the role of psychopharmacology in the management of children would be well addressed by the provision of empiric data to advocates who support or challenge these practices.
UR - http://www.scopus.com/inward/record.url?scp=0028921469&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028921469&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0028921469
VL - 4
SP - 77
EP - 95
JO - Child and Adolescent Psychiatric Clinics of North America
JF - Child and Adolescent Psychiatric Clinics of North America
SN - 1056-4993
IS - 1
ER -